EPIC iO and Ronald McDonald House Join Forces to Protect Families with AURA™ Disinfection System FORT MILL, S.C., May 10, 2023 (GLOBE NEWSWIRE) -- EPIC iO, a technology leader in applied AIoT (Artificial Intelligence and Internet of Things), has announced that its ground-breaking EPIC iO AURA™...

SAB Biotherapeutics Provides Company Update and Reports Full Year 2021 Financial Results SAB executing on its strategy to build a proprietary immune and autoimmune disorders pipeline, including respiratory diseases that affect immunocompromised patients Plans to announce full data...

ENT and Allergy Associates® Welcomes Fellowship-Trained Allergist/Immunologist Omar Waqar, MD Tarrytown, New York, Jan. 27, 2022 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA) recognizes that as the population and healthcare needs of the communities it serves continue to rise, so...

SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company Completed Business Combination with Big Cypress Acquisition Corp. Common stock to commence trading on the Nasdaq Global Market October 25, 2021, under the ticker symbol “SABS” SIOUX FALLS, S.D.,...